Compare

Context Therapeutics Inc. vs Spero Therapeutics, Inc. vs Corvus Pharmaceuticals, Inc. vs Incannex Healthcare Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearContext Therapeutics Inc.
CNTX
Spero Therapeutics, Inc.
SPRO
Corvus Pharmaceuticals, Inc.
CRVS
Incannex Healthcare Inc.
IXHL
Year ended2025-12-312025-12-312025-12-312026-06-30
Revenuen/a$66.80Mn/a$0
Revenue growth (YoY)n/a+39.2%n/a-100.0%
Gross marginn/an/an/an/a
Operating marginn/a9.5%n/an/a
Net marginn/a12.8%n/an/a
Net income-$36.12M$8.57M-$15.28M-$19.30M
EPS (Diluted)-$0.38$0.15-$0.53-$1.66
Operating cash flow-$26.39M-$12.62M-$32.80M-$12.87M
Free cash flow-$26.42Mn/a-$32.97M-$12.88M
Cash & equivalents$66.00M$40.27M$4.58M$67.71M
Total assets$68.49M$68.92M$71.12M$72.98M
Total liabilities$8.02M$9.90M$9.91M$5.61M
Shareholders' equity$60.47M$59.02M$61.20M$67.37M
Return on year-end equity-59.7%14.5%-25.0%-28.6%
Shares outstanding91.88M56.41M74.70M12.54M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearContext Therapeutics Inc.Spero Therapeutics, Inc.Corvus Pharmaceuticals, Inc.Incannex Healthcare Inc.
Latestn/a$66.80M
Ended 2025-12-31
n/a$0
Ended 2026-06-30
1 year earliern/a$47.98M
Ended 2024-12-31
n/a$86.0K
Ended 2025-06-30
2 years earliern/a$103.78M
Ended 2023-12-31
n/a$12.0K
Ended 2024-06-30
3 years earliern/a$53.51M
Ended 2022-12-31
n/an/a
4 years earliern/a$18.26M
Ended 2021-12-31
n/an/a